Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
DV.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.11.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.11.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.11.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
XBB.1.11.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GJ.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GJ.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GJ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GJ.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HJ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HJ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HJ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HJ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.101ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.101ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.101ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.101NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.31ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.31NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.28ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15038.3France
XBB.1.5.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.1.5.28NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GB.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GB.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GB.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GB.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FY.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FY.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.4.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.4.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.4.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.4.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FD.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FD.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FD.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used